Page last updated: 2024-10-29

isoproterenol and Retinopathy of Prematurity

isoproterenol has been researched along with Retinopathy of Prematurity in 1 studies

Isoproterenol: Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant.
isoprenaline : A secondary amino compound that is noradrenaline in which one of the hydrogens attached to the nitrogen is replaced by an isopropyl group. A sympathomimetic acting almost exclusively on beta-adrenergic receptors, it is used (mainly as the hydrochloride salt) as a bronghodilator and heart stimulant for the management of a variety of cardiac disorders.

Retinopathy of Prematurity: A bilateral retinopathy occurring in premature infants treated with excessively high concentrations of oxygen, characterized by vascular dilatation, proliferation, and tortuosity, edema, and retinal detachment, with ultimate conversion of the retina into a fibrous mass that can be seen as a dense retrolental membrane. Usually growth of the eye is arrested and may result in microophthalmia, and blindness may occur. (Dorland, 27th ed)

Research Excerpts

ExcerptRelevanceReference
"Isoproterenol was administered subcutaneously."1.38Beta-adrenoreceptor agonism influences retinal responses to hypoxia in a model of retinopathy of prematurity. ( Bagnoli, P; Dal Monte, M; Filippi, L; Latina, V; Martini, D; Pavan, B, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dal Monte, M1
Martini, D1
Latina, V1
Pavan, B1
Filippi, L1
Bagnoli, P1

Other Studies

1 other study available for isoproterenol and Retinopathy of Prematurity

ArticleYear
Beta-adrenoreceptor agonism influences retinal responses to hypoxia in a model of retinopathy of prematurity.
    Investigative ophthalmology & visual science, 2012, Apr-24, Volume: 53, Issue:4

    Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Animals; Arrestins; beta-Arrestins; Blood Pressure; Blo

2012